Longenesis
Financials
Estimates*
USD | 2021 | 2022 | 2023 |
---|---|---|---|
Revenues | 2.1m | 2.2m | 2.2m |
% growth | - | 5 % | - |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
€40.0k | Grant | ||
$1.2m | Seed | ||
N/A | - | ||
Total Funding | €1.1m |
Recent News about Longenesis
EditLongenesis operates in the healthcare technology sector, providing a digital platform designed to streamline the collection, compilation, and analysis of patient data. The company primarily serves healthcare researchers, biomedical institutions, and patient organizations. By facilitating the efficient handling of patient data, Longenesis aims to promote collaboration between various stakeholders in the biomedical field. The platform is particularly valuable for projects involving rare diseases, which require meticulous data management and analysis. Longenesis generates revenue through subscription fees for its platform, offering different pricing tiers based on the scale and needs of the client. The company’s business model focuses on providing a scalable, secure, and user-friendly solution that enhances research efficiency and data security.
Keywords: healthcare technology, patient data, biomedical research, digital platform, data analysis, rare diseases, collaboration, subscription model, data security, research efficiency.